ISRCTN42132522Completed未知
Determining the optimal approach to identifying individuals with chronic obstructive pulmonary disease: a multi-centre randomised trial
niversity of York (UK)0 sites600 target enrollmentStarted: March 31, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 600
Study Overview
Brief Summary
- 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29536597
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Current smokers aged 35 years or more who are registered with participating GP practices
Exclusion Criteria
- •1. Pregnancy
- •2. Recent history (within 8 weeks) of myocardial infarction, stroke, pulmonary embolism, chest/abdominal surgery or eye surgery
- •3. Any mental or physical condition (e.g. chest/abdominal pain/stress incontinence) or any other condition which means the participant is unable to undergo the case-finding tools
Investigators
Similar Trials
Completed
Not Applicable
Observational study to predict readmission for heart failure patientsTopic: CardiovascularSubtopic: Cardiovascular (all Subtopics)Disease: CardiovascularCirculatory SystemHeart failureISRCTN96643197Hull and East Yorkshire Hospitals NHS Trust1,145
Completed
Not Applicable
Method comparison and bias estimation of point of care creatinine testSpecialty: Renal disorders, Primary sub-specialty: Renal disordersUKCRC code/ Disease: Blood/ Other diseases of blood and blood-forming organsUrological and Genital DiseasesISRCTN18805212Mid Yorkshire Hospitals NHS Trust300
Active, not recruiting
Not Applicable
To determine the optimum series of investigations to diagnose asthmaRespiratoryAsthmaISRCTN11676160Manchester University NHS Foundation Trust300
Completed
Not Applicable
The ADENOMA study - a study of a device to improve detection of polyps during colonoscopyConditions requiring colonoscopy assessment, colonic adenomasDigestive SystemISRCTN11821044South Tyneside NHS Foundation Trust (UK)1,772
Terminated
Not Applicable
System for Determining Ideal Drug Doses for ADHD - Stages 1 and 2Attention Deficit Hyperactivity DisorderNCT03523663University of Wisconsin, Madison46